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ABSTRACT
Tuberculosis remains a major global health problem. Laboratory diagnostic methods
that allow effective, early detection of cases are central to management of tuberculosis
in the individual patient and in the community. Since the 1880s, laboratory diagnosis
of tuberculosis has relied primarily on microscopy and culture. However, microscopy
fails to provide species- or lineage-level identification and culture-based workflows
for diagnosis of tuberculosis remain complex, expensive, slow, technically demanding
and poorly able to handle mixed infections. We therefore explored the potential
of shotgun metagenomics, sequencing of DNA from samples without culture or
target-specific amplification or capture, to detect and characterise strains from the
Mycobacterium tuberculosis complex in smear-positive sputum samples obtained
from The Gambia in West Africa. Eight smear- and culture-positive sputum samples
were investigated using a differential-lysis protocol followed by a kit-based DNA
extraction method, with sequencing performed on a benchtop sequencing instru-
ment, the Illumina MiSeq. The number of sequence reads in each sputum-derived
metagenome ranged from 989,442 to 2,818,238. The proportion of reads in each
metagenome mapping against the human genome ranged from 20% to 99%. We were
able to detect sequences from the M. tuberculosis complex in all eight samples, with
coverage of the H37Rv reference genome ranging from 0.002X to 0.7X. By analysing
the distribution of large sequence polymorphisms (deletions and the locations of
the insertion element IS6110) and single nucleotide polymorphisms (SNPs), we
were able to assign seven of eight metagenome-derived genomes to a species and
lineage within the M. tuberculosis complex. Two metagenome-derived mycobacterial
genomes were assigned to M. africanum, a species largely confined to West Africa; the
others that could be assigned belonged to lineages T, H or LAM within the clade of
“modern” M. tuberculosis strains. We have provided proof of principle that shotgun
metagenomics can be used to detect and characterise M. tuberculosis sequences from
sputum samples without culture or target-specific amplification or capture, using an
accessible benchtop-sequencing platform, the Illumina MiSeq, and relatively simple
DNA extraction, sequencing and bioinformatics protocols. In our hands, sputum
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metagenomics does not yet deliver sufficient depth of coverage to allow sequence-
based sensitivity testing; it remains to be determined whether improvements in DNA
extraction protocols alone can deliver this or whether culture, capture or amplifica-
tion steps will be required. Nonetheless, we can foresee a tipping point when a unified
automated metagenomics-based workflow might start to compete with the plethora
of methods currently in use in the diagnostic microbiology laboratory.
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INTRODUCTION
Tuberculosis (TB) is an infection, primarily of the lungs, caused by Mycobacterium
tuberculosis and related species within the M. tuberculosis complex. TB remains a major
global health problem, second only to HIV/AIDS in terms of global deaths from a single
infectious agent—according to estimates from the World Health Organisation (WHO),
8.6 million people developed TB in 2012 and 1.3 million died from the disease, including
320,000 deaths among HIV-positive individuals (WHO, 2013).
Central to management of TB in the individual patient and in the community are
laboratory diagnostic methods that allow effective, early detection of cases. Since the
pioneering work of Koch and Ehrlich in the 1880s, laboratory diagnosis of pulmonary
TB has largely relied on acid-fast staining of sputum samples and culture on selective
laboratory media for the isolation of mycobacteria (Ehrlich, 1882; Koch, 1882). Microscopy
is still generally used as a first-line diagnostic approach and as the only laboratory approach
in resource-poor settings (Drobniewski et al., 2012) Smear-positivity is also used as a
guide to infectivity and responsiveness to treatment. However, microscopy fails to provide
species-level identification of acid-fast bacilli (Maiga et al., 2012). Such identification
is important in guiding treatment, because pathogenic mycobacteria from outside the
M. tuberculosis complex often fail to respond to conventional anti-TB treatment (Maiga
et al., 2012). Furthermore, there are important differences in response to treatment even
within the M. tuberculosis complex. M. bovis and M. canettii fail to respond to the first-line
anti-tuberculous agent pyrazinamide—as a result, failure to recognise M. bovis as a cause
of TB can have fatal consequences (Allix-Beguec et al., 2010). In addition, M. canettii
appears to show decreased susceptibility to a promising new anti-TB drug candidate,
PA-824 (Feuerriegel et al., 2011; Feuerriegel et al., 2013).
There is also increasing recognition of lineage- or species-specific differences in
pathogen biology within the M. tuberculosis complex. M. africanum, which is largely
restricted to West Africa, where it causes up to half of human pulmonary TB, is associated
with less transmissible and less severe infection than typical strains of the “modern”
M. tuberculosis clade (de Jong, Antonio & Gagneux, 2010). Similarly, M. canettii, restricted
to the horn of Africa, and M. bovis, both usually a spillover from animals, transmit
relatively poorly from human to human (Fabre et al., 2010; Gonzalo-Asensio et al., 2014).
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By contrast, the Beijing-W lineage of M. tuberculosis sensu stricto, which has spread around
the world in recent decades, appears to cause more aggressive disease and is more likely to
become drug-resistant (Nicol &Wilkinson, 2008; Borgdorff& van Soolingen, 2013).
Owing to the slow growth rate of the M. tuberculosis complex, traditional culture-based
diagnosis of TB typically takes several weeks or even months. Similarly, conventional
phenotypic mycobacterial sensitivity testing remains slow and may not be reliable for all
classes of anti-tuberculous agent. In recent decades, automated detection of growth in
liquid culture, through e.g. the mycobacteria growth indicator tube (MGIT), has led to
improvements in the speed and ease of diagnosis, so that diagnosis by culture is now often
possible within a fortnight (Pfyffer et al., 1997).
However, in comparison to most other laboratory procedures, culture-based diagnostic
workflows for TB remain complex, expensive, slow, technically demanding and require
expensive biocontainment facilities. Furthermore, as isolation of mycobacteria in pure
culture and sensitivity testing remain onerous, in resource-poor settings these steps are
omitted and, even in well-resourced laboratories, typically only one or a few single-colony
subcultures are followed up from each sample. This leads to under-recognition of mixed
infections, where more than one strain from the M. tuberculosis complex is present or
where TB co-occurs with infection by other mycobacteria (Shamputa et al., 2004; Warren
et al., 2004; Cohen et al., 2011; Wang et al., 2011). This can lead to difficulties in treatment
when strains or species susceptible to conventional anti-tuberculous treatment co-exist
with resistant strains or species within the same patient (Hingley-Wilson et al., 2013).
As an alternative to culture and phenotypic sensitivity testing, the WHO has recently
recommended a new, rapid, automated, real-time amplification-based TB diagnostic test,
the Xpert MTB/RIF assay (WHO, 2011). This system allows simultaneous detection of
M. tuberculosis and rifampicin-resistance mutations in a closed system, suitable for use in a
simple laboratory setting, while providing a result in less than two hours directly from spu-
tum samples (Helb et al., 2010). However, this approach performs suboptimally on mixed
infections, fails to provide the full range of clinically relevant information (e.g., speciation,
susceptibility to other agents) and, in sampling only a small fraction of the genome, affords
no insight into pathogen biology, evolution, and epidemiology (Zetola et al., 2014).
Epidemiological investigation of clinical isolates from the M. tuberculosis complex plays
an important role in the management and control of TB. A range of molecular typing
schemes have been developed, including IS6110 fingerprinting, mycobacterial interspersed
repetitive unit-variable number of tandem repeat (MIRU-VNTR) and spoligotyping
(Jagielski et al., 2014). These approaches can be valuable in distinguishing relapse from
re-infection and in recognising mixed infections within the individual patient, as well as
identifying sources of infection, detecting outbreaks and tracking spread of lineages within
a community. However, as these approaches usually require isolation of the pathogen in
pure culture, clinically relevant typing data is typically not available until 1–2 months after
collection of a sputum sample.
Over the past fifteen years, whole-genome sequencing has been applied to a steadily
wider range of isolates from M. tuberculosis and related species (Cole et al., 1998;
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Brosch et al., 2002; Gutierrez, Supply & Brosch, 2009). These efforts have shed light on the
evolution and population structure of this group of pathogens, showing that members of
the M. tuberculosis complex are reproductively isolated, engaging in almost no horizontal
gene transfer and showing a clonal population structure in which lineages diverge through
a limited set of genetic changes, including point mutations, deletions, movement of
insertion elements and rearrangements within repetitive regions. Whole-genome analyses
allow isolates to be assigned to a range of species, global lineages and sub-lineages on
the basis of single nucleotide polymorphisms (SNPs) and large sequence polymorphisms
(typically deletions, which are often termed “regions of difference” or RDs, and insertion of
the transposable element IS6110).
In recent years, the availability of rapid, cheap high-throughput sequencing and,
particularly, the arrival of user-friendly benchtop sequencing platforms, such as the
Illumina MiSeq (Loman et al., 2012a; Loman et al., 2012b), have led to the widespread
use of whole-genome sequencing in TB sensitivity testing and epidemiology, with adoption
of whole-genome sequencing for routine use in some TB reference laboratories (Gardy
et al., 2011; Koser et al., 2012; Roetzer et al., 2013; Walker et al., 2013; Walker et al., 2014).
However, high-throughput sequencing has not yet been used as a diagnostic tool for TB,
because it has been assumed that one needs to subject clinical samples to prolonged culture
before sufficient mycobacterial DNA can be obtained for whole-genome sequencing and
analysis. Some researchers (Koser et al., 2013) have recently challenged this assumption by
obtaining mycobacterial genome sequences from DNA extracted directly from a three-day
MGIT culture of a sputum sample. However, this begs the questions: why bother with
culture; why not obtain mycobacterial genome sequences directly from a sputum sample,
without culture?
Shotgun metagenomics—that is the unbiased sequencing en masse of DNA extracted
from a sample without target-specific amplification or capture—has provided a powerful
assumption-free approach to the recovery of bacterial pathogen genomes from contem-
porary and historical material (Pallen, 2014). This approach allowed an outbreak strain
genome to be reconstructed from stool samples from the 2011 Escherichia coli O104:H4
outbreak and has proven successful in obtaining genome-wide sequence data for Borrelia
burgdorferi, M. leprae, M. tuberculosis and Brucella melitensis from long-dead human
remains (Keller et al., 2012; Chan et al., 2013; Loman et al., 2013; Schuenemann et al., 2013;
Kay et al., 2014). Metagenomics has recently provided clinically useful information in cases
of chlamydial pneumonia and neuroleptospirosis (Fischer et al., 2014; Wilson et al., 2014).
Here, we explore the potential of metagenomics in detecting and characterising
Mycobacterium tuberculosis and M. africanum strains in smear-positive sputum samples
from patients from The Gambia in West Africa.
MATERIALS AND METHODS
Microbiological analysis and sample selection
Eight smear- and culture-positive sputum samples were selected for metagenomic
analysis from specimens collected in May 2014 under the auspices of the Enhanced
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Case Finding project (http://clinicaltrials.gov/show/NCT01660646). The joint Gambia
Government/MRC Ethics Committee approved this investigation under reference SCC
1232 and informed written consent was obtained for all participants. The sputum samples
were collected by expectoration into a sterile cup and transported on ice to the TB
laboratory at the MRC Gambia unit within 24 h of collection.
Prior to selection for metagenomic investigation, an aliquot of each sample was sub-
jected to microbiological analysis. These specimens were decontaminated by the sodium
hydroxide and N-acetyl-l-cysteine (NaOH/NALC) method, with final concentrations
of 1% for NaOH, 1.45% sodium citrate and 0.25% for NALC. Sputum smears were
prepared by centrifuging 3–10 mL decontaminated sputum and then resuspending pellets
in 2 mL buffer. Smears were stained with auramine-O and then examined by fluorescence
microscopy. Positive smears were confirmed by Ziehl-Neelsen staining. 20–100 fields were
examined at 1000X magnification and smear-positive samples were scored quantitatively
as 1+, 2+ or 3+ (Kent & Kubica, 1985).The presence of M. tuberculosis complex in samples
was confirmed by culture in the BACTEC MGIT 960 Mycobacterial Detection System and
on slopes of Lo¨wenstein–Jensen medium. Cultured isolates were subjected to spoligotyping
as previously described (Kamerbeek et al., 1997; de Jong et al., 2009).
DNA extraction using differential lysis
DNA extraction was performed in the TB laboratory in the MRC Unit in The Gambia.
Aliquots of unprocessed sputum were subjected to a differential lysis protocol, modified
from a published method for metagenomic analysis of sputum from cystic fibrosis patients
(Lim et al., 2013). In this method, human cells are subjected to osmotic lysis and then the
liberated human DNA is removed by DNase treatment. To monitor contamination within
the laboratory, we processed two negative-control samples containing only sterile water via
the same method.
At the start of the differential lysis protocol, a 1 mL aliquot of whole sputum was
mixed with 1 mL decongestant solution (0.25 g N-acetyl L-cysteine, 25 mL 2.9% sodium
citrate, 25 mL water) until liquefied and incubated for 15 min at room temperature.
48 mL phosphate-buffered solution (pH 7) was added and mixed thoroughly, before
centrifugation at 3,220 × g for 20 min. The pellet was resuspended in 10 mL sterile
deionised water and incubated at room temperature for 15 min, so that human cells
undergo osmotic lysis, while mycobacterial cells remain intact. The centrifugation and
resuspension-in-water steps were repeated before a final round of centrifugation. The
pellet was then treated with the RNase-Free DNase Set (Qiagen), adding 25 µL DNase I
(2.73 Kunitz units per µL), 100 µL RDD buffer and 875 µL sterile water. The sample was
then incubated at room temperature for 2 h, with repeated inversion of the tubes. The
sample underwent two rounds of centrifugation and resuspension of the pellet in 10 mL
TE buffer (0.01 M Tris–HCl, 0.001 M EDTA, pH 8.0). Finally, before DNA extraction
began, the sample was centrifuged and the pellet was resuspended in 500 µL TE buffer.
On completion of the differential lysis protocol, samples underwent heat treatment at
75 ◦C for 10 min, followed by DNA extraction using a commercial kit, the NucleoSpin
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Tissue-Kit (Macherey-Nagel, Duren, Germany), according to the manufacturer’s protocol
for hard-to-lyse bacteria.
Library preparation and sequencing
DNA samples were sent to Warwick Medical School, Coventry, UK, where all further lab-
oratory and bioinformatics analyses were performed. The concentration of DNA present
in each extract was determined using the Qubit 2.0 fluorometer and Qubit® dsDNA
Assay Kits according to the manufacturer’s protocol (Invitrogen Ltd., Paisley, United
Kingdom), using the HS (high-sensitivity) or BR (broad-range) kits, depending on
the DNA concentration. There was no detectable DNA in the negative control samples
with the HS kit, which is sensitive down to 10 pg/µL. DNA extracts were diluted to
0.2 ng/µL and were then converted into sequencing libraries, using the Illumina Nextera
XT sample preparation kit according to the manufacturer’s instructions (Illumina UK,
Little Chesterford, United Kingdom). The libraries were sequenced on the Illumina MiSeq
at the University of Warwick.
Identification of human and mycobacterial sequences
Sequence reads were mapped against the genome of Mycobacterium tuberculosis H37Rv
(GenBank accession numbers AL123456) and the human reference genome hg19
(GenBank Assembly ID: GCA 000001405.1), using Bowtie2 version 2.1.0 (Langmead &
Salzberg, 2012), using relaxed and stringent protocols. The relaxed protocol exploited
the option --very-sensitive-local. The stringent protocol allowed only limited
mismatches (3 per 100 base pairs) and soft clipping of poor quality ends, by exploiting the
options --ignore-quals --mp 10,10 --score-min L,0,0.725 --local --ma
1. A custom-built script was used to convert coverage data from the BAM files into a
tab-delineated format that was then entered into Microsoft Excel, which was then used to
generate coverage plots. Metagenomic sequence reads from this study (excluding those that
mapped to the human genome) have been deposited in the European Nucleotide Archive
under the following accession numbers: ERS542292, ERS542293, ERS542294, ERS542295,
ERS542296, ERS542297, ERS542298, ERS542299.
Species and lineage assignment using low-coverage SNPs
For the phylogenetic analysis using SNPs, we selected representative genomes from each
of the species and major lineages within the M. tuberculosis complex that infect humans,
drawing on lineage designations reported by PolyTB (Coll et al., 2014). Genome sequences
were taken from entries in the short read archive ERP000276 and ERP000124 (http://www.
ncbi.nlm.nih.gov/Traces/sra/). We then mapped these genomes against M. tuberculosis
H37Rv with Bowtie2 under default settings and then called SNPs using VarScan2 (Koboldt
et al., 2012). Any SNPs that fell within a set of previously published repetitive genes were
excluded from further analysis (Comas et al., 2010). SNPs were used to construct a tree
with RAxML version 7 (Stamatakis, 2014), using default parameters with the GTR-gamma
model. Reads from the metagenome from each sample were mapped against the reference
strain M. tuberculosis H37Rv using the default settings in Bowtie2 and the majority base
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Table 1 Sample characteristics and sequencing results.
Sample ZN
grade
DNA concentration
in extract (µg/mL)
Total no. reads % reads aligning to
human genome
K1 3+ 27.8 989,442 73.71
K2 3+ 2.28 2,170,640 78.46
K3 2+ 71 1,617,808 99.3
K4 2+ 250 1,204,408 97.22
K5 2+ 7.7 1,537,676 74.17
K6 2+ 48.8 2,411,708 97.47
K7 1+ 25 2,818,238 50.59
K8 1+ 0.63 1,851,892 20.29
called from each SNP position with no quality filtering. If no base was present at the
position, a gap was used. The pplacer suite of programs (Matsen, Kodner & Armbrust, 2010)
was then used to assign the sequence to a species and lineage on the mycobacterial tree.
Lineage assignment using IS6110-insertion-site profiles
We mapped each metagenome against the sequence of IS6110 (Genbank accession
number: AJ242908) using Bowtie’s --local option, which performs a softclipping of
the mapped sequences. We then extracted IS6110-flanking sequences by retrieving all
sequences >30 bp that had that had been softclipped from the ends of the element.
These sequences were then mapped against the H37Rv genome using Bowtie2 and the
coordinates of the IS6110 insertion points determined.
RESULTS
Detection of the M. tuberculosis complex in sputum samples
We obtained metagenomic sequences from eight smear- and culture-positive sputum
samples. The number of sequence reads in each sputum-derived metagenome ranged from
989,442 to 2,818,238 (Table 1). The proportion of reads from each sample mapping to the
human reference genome hg19 varied from 20% to 99%.
Coverage from reads mapping to the genome of the M. tuberculosis reference strain
H37Rv under relaxed settings ranged from 0.009X to 1.3X (Table 2). However, we
suspected that many of the matches represented false-positives. To confirm our suspicion,
we calculated the average read depth at the positions where reads matched.
If the matches occurred because of sequence identity with conserved genes from other
species, one would expect there to be multiple reads matching each mapped position,
whereas for a shotgun library where the coverage is less than 1X, one would expect the
average read depth to be around 1. However, as we created our sequence libraries using
a paired-end protocol, there will be variable overlap between reads originating from the
same DNA fragment, so one would expect the average read depth for a genuine random
shotgun under these conditions to sit between 1 and 2. However, when mapping was
performed under relaxed conditions, the average read depth was >2 in six of the eight
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Table 2 Mapping to M. tuberculosis H37Rv reference genome.
Sample Under relaxed mapping conditions Under stringent mapping conditions
Bases aligning
to H37Rv
Coverage of
H37Rv
Average read
depth
Bases aligning
to H37Rv
Coverage of
H37Rv
Average
read depth
K1 410,228 0.093 2.2 141,906 0.032 1.3
K2 5,685,901 1.289 2.3 3,057,187 0.693 1.9
K3 99,643 0.023 1.3 54,413 0.012 1.2
K4 40,019 0.009 1.9 10,840 0.002 1.3
K5 732,623 0.166 2.5 238,451 0.054 1.3
K6 94,023 0.021 2.3 34,704 0.008 1.7
K7 1,366,309 0.310 11.4 50,873 0.012 1.5
K8 1,725,816 0.391 7.7 109,514 0.025 1.3
samples and in two cases was>7 (Table 2), indicating a major contribution from spurious
matches to conserved genes.
To restrict matches to the H37Rv genome to genuine on-target alignments, we then
mapped each metagenome against the reference strain under high-stringency conditions
(≤3 mismatches per 100 base pairs, with soft clipping of poor quality ends). This led
to a decrease in reads mapping to H37Rv in all samples, with coverage of the H37Rv
under stringent settings ranging from 0.002X to 0.7X. Nonetheless, we recovered between
∼11,000 and 3 million base pairs of M. tuberculosis sequence from our samples under such
stringent conditions (Table 2). The average read depth in the samples fell to between 1.2
and 1.9, consistent with expectations for a random shotgun (Table 2).
Phylogenetic placement of M. tuberculosis strains using SNPs
Conventional phylogenetic methods based on identification of trusted SNPs cannot be
applied to the kinds of low-coverage genome sequences we have obtained here. However,
the technique of “phylogenetic placement” provides an alternative solution (Matsen,
Kodner & Armbrust, 2010; Kay et al., 2014). Here, one draws on a fixed reference tree,
computed from high-coverage genomes, and places the unknown query sequence on to
the tree using programs such as pplacer (Matsen, Kodner & Armbrust, 2010). To perform
phylogenetic placements on our samples, we derived a set of phylogenetically informative
SNPs from representatives of the major lineages within the M. tuberculosis complex. We
then analysed reads from each of the sputum metagenomes that aligned to equivalent
positions in the H37Rv genome.
Using this approach, despite the low coverage, we could confidently assign (with a
posterior probability of >0.97), all but one of the metagenome-derived mycobacterial
genomes to a species and lineage within the M. tuberculosis complex (Fig. 1). In all these
cases, the conclusions from metagenomics matched those from spoligotyping of cultured
isolates (Table 3). For two of the samples (K3, K5), the metagenome-derived genome was
assigned to M. africanum clade 2, which is consistent with the known high-prevalence
of this lineage in The Gambia (de Jong et al., 2010). Five samples were assigned to the
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Figure 1 Maximum likelihood tree showing placement of mycobacterial metagenome-derived
genomes amongst the major lineages and clades within the M. tuberculosis complex. Detection and
characterisation of Mycobacterium tuberculosis in sputum samples using shotgun metagenomics. Two
representatives from each lineage/clades are shown. Tree calculated using RaXML and rooted with
M. canetti (not shown).
Euro-American lineage (also termed Lineage 4), which sits within the clade of modern M.
tuberculosis strains and which is known to be highly prevalent in The Gambia (de Jong et al.,
2010). Phylogenetic placement allowed three of these samples to be assigned to sub-lineage
H, one to the T-clade and one to the LAM clade.
Species and lineage assignment using IS6110 insertion sites
From four samples, we were able to retrieve information on IS6110 insertion sites
(Table 4). In two of the three samples (K2, K4) assigned to the H clade by phylogenetic
placement, we discovered IS6110 insertion sites that had previously been reported as
specific to the Haarlem or H clade (HSI1, HSI2, HSI3), thereby confirming the SNP-based
lineage assignment (Cubillos-Ruiz et al., 2010). In the sample assigned to the LAM clade, we
retrieved information on a single IS6110 insertion site, which disrupts the coding sequence
Rv3113. This insertion has been reported as specific to the LAM clade (Lanzas et al., 2013),
again confirming the SNP-based lineage assignment. In one of the two samples assigned
to M. africanum, we retrieved information on a single IS6110 insertion site. However, this
insertion appeared to be absent from all other available genome-sequenced strains from
the M. tuberculosis complex, so was phylogenetically uninformative.
DISCUSSION
Here, we have provided proof of principle that shotgun metagenomics can be used to
detect and characterise M. tuberculosis sequences from sputum samples without culture
or target-specific amplification or capture, using an accessible benchtop-sequencing
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Table 3 Species and lineage assignments by phylogenetic placement and spoligotyping.
Sample Phylogenetic placement by pplacer Spoligotyping
Species, lineage, clade Posterior probability Lineage Spoligotype
K1 M. tuberculosis
Euro-American /
Lineage 4
LAM clade
1 Euro-American 1101111111110111111100001111111100001111011
K2 M. tuberculosis
Euro-American /
Lineage 4
H clade
1 Euro-American 1111111111111111111111111111110100001111111
K3 M. africanum
Lineage 6
M. africanum clade 2
1 West African 2 1111110001111111111000001000011111111101111
K4 M. tuberculosis
Euro-American /
Lineage 4
H clade
0.99 Euro-American 1111111111111111111111111111110100001111111
K5 M. africanum
Lineage 6
M. africanum clade 2
1 West African 2 1111110001111111111111111111111111111101111
K6 Not determined West African 2 1111110001111111111111111111111111111101111
K7 M. tuberculosis
Euro-American /
Lineage 4
H clade
0.97 Euro-American 1111111111111111111111111111110100001111111
K8 M. tuberculosis
Euro-American /
Lineage 4
T clade
1 Euro-American 1111110000000000000000000111111100001111111
platform, the Illumina MiSeq, and relatively simple DNA extraction, sequencing and
bioinformatics protocols.
There are several proven or potential advantages to metagenomics as a diagnostic
approach for pulmonary TB. By circumventing the need for culture, it could provide
information more quickly than conventional approaches. Even in this proof-of-principle
study, for most samples it has provided more detailed information than conventional
approaches, including spoligotyping. In addition, it represents an open-ended one-size-
fits-all approach that could allow the reunification of TB microbiology with other sputum
microbiology, particularly as metagenomics has already been shown to work on other
respiratory tract pathogens, including bacteria and viruses (Lysholm et al., 2012; Fischer et
al., 2014). It also aids in the detection of mixed infections (Chan et al., 2013; Koser et al.,
2013), which are clinically important, but hard to recognise (Shamputa et al., 2004; Warren
et al., 2004; Cohen et al., 2011; Wang et al., 2011; Hingley-Wilson et al., 2013).
However, as things stand, there are several important limitations to metagenomics as a
diagnostic approach. Our study has been limited to the investigation of smear-positive
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Table 4 IS6110 profiles.
Sample No. reads
mapping to IS6110
No. reads spanning
IS6110 insertion site
IS6110
insertion site coordinates
Comments
K1 11 1 3480371 Specific to LAM clade
K2 199 22 2610861 (HSI1), 1075947–1075950 (HSI2),
1715974 (HSI3).
212132–212135, 483295–483298, 888787,
1695606, 1986622–1986625, 3120523
HSI1, HSI2, HSI3
specific to H clade:
K3 2 0 Not determined
K4 6 2 2610861–2610864 (HSI1) HSI1 specific to H clade
K5 4 1 2631765 Unique so
uninformative
K6 0 0 Not determined
K7 2 0 Not determined
K8 5 0 Not determined
sputum samples, where a diagnosis can already be obtained quickly and easily by
microscopy; considerable improvements in sensitivity are likely to be needed before
metagenomics can be made to work on smear-negative culture-positive samples. However,
it is worth stressing that smear-positive cases are the most important TB cases in terms
of infectivity and severity of disease and rapid, accurate diagnosis and epidemiological
investigation of such samples is likely to aid TB control (Shaw & Wynn-Williams, 1954;
Colebunders & Bastian, 2000; Wang et al., 2008). Plus, for all our samples, metagenomics
goes beyond mere detection of acid-fast bacilli to deliver clinically important information
at the level of species and lineage within the M. tuberculosis complex.
Surprisingly, metagenomics has not proven quite so informative when applied to
contemporary sputum samples as when applied to historical samples, from which we
have gained much higher coverage of pathogen genomes, which allowed recognition
of phylogenetically informative large sequence polymorphisms (Chan et al., 2013; Kay
et al., 2014). Furthermore, in our hands, sputum metagenomics does not yet deliver
sufficient depth of coverage of TB genomes to allow the accurate SNP calling necessary for
sequence-based sensitivity testing. It remains unclear whether increased depth of coverage
can be achieved by refinements in DNA extraction protocols alone—or whether one might
need to sacrifice the speed, simplicity and open-endedness of shotgun metagenomics by
incorporating amplification of mycobacterial DNA or cells (i.e., by culture in MGIT tubes
(Koser et al., 2013)) or by capture of mycobacterial cells or DNA (Sweeney et al., 2006;
Bouwman et al., 2012; Schuenemann et al., 2013).
Some have argued that metagenomics is too expensive for routine use (Ko¨ser, Ellington
& Peacock, 2014). However, the same was true of whole-genome sequencing a few
years ago; in this study, reagent costs amounted to <£50 per sample. Plus, with minor
modifications, we anticipate that DNA extraction could be completed in a few hours of
receipt of a sputum sample and sequencing and analysis within a few days. In addition,
now that cultured TB isolates are being routinely genome sequenced in many laboratories
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(Koser et al., 2012; Kohl et al., 2014), a catalogue of local TB genomes will be available for
comparison with the metagenome-derived genomes, facilitating epidemiological analyses
With likely future improvements in the ease, throughput and cost-effectiveness of
sequencing, twinned with commoditisation of laboratory and informatics workflows,
one can foresee a tipping point when a unified automated metagenomics-based workflow
might start to compete with the plethora of methods currently in use in the diagnostic
microbiology laboratory, while also delivering additional useful information on epidemi-
ology, antimicrobial resistance and pathogen biology.
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